MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corp (OTC:RMCP) has set certain goals for this summer that when completed should add value to its stock. These goals should propel the company forward as it enters the sales and marketing phase of its business plan. The company has been working towards 510K FDA submission for its RevVac safety syringe for the past several months. Its first goal is to complete and file this submission for all sizes of its safety syringe including 1cc, 3cc, 5cc, and 10cc with the FDA. Rev Med has hired and announced the two companies that are handling the submittal and the lab testing: Strategic Product Development and Son Medical. This syringe uses vacuum technology to suck the needle into the plunger after use. The syringe cannot be reused once the vacuum is activated. Rev Med believes its safety syringe has many advantages over its competition including price, ease of use, and safety. It should help reduce accidental needle stick injuries and also aid in reducing the spread of contagious diseases. You may view a video of the syringe in use on are website at www.revolutionsmedical.com. The company also believes that with the help of government regulation initiatives, individual state laws, and the importance of world health concerns, the safety syringe market will continue to have substantial growth into the foreseeable future.
